Literature DB >> 32423954

Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste.

James T Gordy1, Kaushiki Mazumdar2, Noton K Dutta3.   

Abstract

Entities:  

Keywords:  COVID-19; FDA-approved drugs; SARS-CoV-2; antiviral drugs; coronavirus disease 2019; host-directed therapy; pathogen-directed therapy; severe acute respiratory syndrome coronavirus-2; treatment

Mesh：

Year:  2020        PMID： 32423954      PMCID： PMC7526802          DOI： 10.1128/AAC.00857-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  25 in total

1.  Hopes rise for coronavirus drug remdesivir.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2020-04-29       Impact factor: 49.962

2.  Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.

Authors:  Sisi Kang; Mei Yang; Zhongsi Hong; Liping Zhang; Zhaoxia Huang; Xiaoxue Chen; Suhua He; Ziliang Zhou; Zhechong Zhou; Qiuyue Chen; Yan Yan; Changsheng Zhang; Hong Shan; Shoudeng Chen
Journal:  Acta Pharm Sin B       Date:  2020-04-20       Impact factor: 11.413

3.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

Authors:  Manli Wang; Ruiyuan Cao; Leike Zhang; Xinglou Yang; Jia Liu; Mingyue Xu; Zhengli Shi; Zhihong Hu; Wu Zhong; Gengfu Xiao
Journal:  Cell Res       Date:  2020-02-04       Impact factor: 25.617

4.  Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.

Authors:  Peter Richardson; Ivan Griffin; Catherine Tucker; Dan Smith; Olly Oechsle; Anne Phelan; Michael Rawling; Edward Savory; Justin Stebbing
Journal:  Lancet       Date:  2020-02-04       Impact factor: 79.321

Review 5.  Updated Approaches against SARS-CoV-2.

Authors:  Haiou Li; Yunjiao Zhou; Meng Zhang; Haizhou Wang; Qiu Zhao; Jing Liu
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

6.  Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.

Authors:  Jasper Fuk-Woo Chan; Anna Jinxia Zhang; Shuofeng Yuan; Vincent Kwok-Man Poon; Chris Chung-Sing Chan; Andrew Chak-Yiu Lee; Wan-Mui Chan; Zhimeng Fan; Hoi-Wah Tsoi; Lei Wen; Ronghui Liang; Jianli Cao; Yanxia Chen; Kaiming Tang; Cuiting Luo; Jian-Piao Cai; Kin-Hang Kok; Hin Chu; Kwok-Hung Chan; Siddharth Sridhar; Zhiwei Chen; Honglin Chen; Kelvin Kai-Wang To; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

Review 7.  Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.

Authors:  Jahan S Khalili; Hai Zhu; Nga Sze Amanda Mak; Yongqi Yan; Yi Zhu
Journal:  J Med Virol       Date:  2020-04-10       Impact factor: 2.327

8.  Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.

Authors:  David S Fedson; Steven M Opal; Ole Martin Rordam
Journal:  mBio       Date:  2020-03-20       Impact factor: 7.867

9.  Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.

Authors:  Fan Wang; Jiayan Nie; Haizhou Wang; Qiu Zhao; Yong Xiong; Liping Deng; Shihui Song; Zhiyong Ma; Pingzheng Mo; Yongxi Zhang
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

10.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700
View more
  1 in total

1.  Antivirals virtual screening to SARS-CoV-2 non-structural proteins.

Authors:  Vinicius S Nunes; Diego F S Paschoal; Luiz Antônio S Costa; Hélio F Dos Santos
Journal:  J Biomol Struct Dyn       Date:  2021-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.